Farida Al Hosani confirmed that it is not necessary

Stopping the fourth dose of the “Covid-19” vaccine

The official spokesman for the health sector in the country, Dr. Farida Al-Hosani, confirmed that there is no need to obtain a fourth dose of the “Covid-19” vaccine, whether the three doses of the Sinopharma vaccine, or the first and second doses of “Sinopharma”, and the third dose of the “Sinopharma” vaccine. “Pfizer”, noting that the dates for the second booster dose have been suspended in the event of a change in the vaccine.

In detail, Al Hosani explained, during her participation in the international forum "Legal Frameworks for an Enhanced Environment for Investment in the Health Sector and Telemedicine in the UAE" organized by the Abu Dhabi Judicial Academy in cooperation with the Abu Dhabi Department of Health, that many individuals received two doses of "Covid-19" vaccination. , During the end of last year and the beginning of this year, when the main vaccine available at the time was the Sinopharm vaccine, noting that the goal of vaccines is to form immune bodies inside the human body to resist disease, and scientific studies showed that the immune bodies that formed the vaccine weaken, to the point that after six months of The second dose may be few immune bodies and not enough to prevent disease, hence the recommendation to give the booster dose, or what some groups of society call the third dose.

She said that this dose is necessary for all groups of society, as it is scheduled three months after the second dose if the person is over 60 years old or suffers from chronic diseases, it is preferable to take the dose at this time, while it is six months after the second dose for the rest of the individuals To modify and raise the proportion of immune bodies in the human body to resist disease.

Al-Hosani added, “So far, there are no other doses after the third dose, and there are some people who suggest, after receiving two doses of the Sinopharm vaccine, that they take the third and fourth dose, and we do not recommend the fourth dose, because the supporting dose is one dose, whether it is from the same vaccination or from another vaccination. ».

And she added that if a person receives two doses of the Sinopharma vaccine, he can get the third dose of the same vaccine or take the third dose of Fayez vaccine, stressing that all options are available and safe, but one supporting dose is considered sufficient and there is no need to take an additional dose after the dose. The third, especially since this is applied globally, and a new dose may be approved after six months or a year, as this topic is still under research and study, and no study has emerged confirming the need for permanent doses.

She pointed out that “there is a risk if (4 or 5) vaccines are taken, and the person may put himself at risk in this matter. If the risk of taking two types of vaccine is 1%, then the possibility of risk increases with the increase in the number of vaccinations, so the vaccination must be for a medical purpose. And not for anything else, so as not to expose ourselves to danger or complications.”

She confirmed that the appointments for the second booster dose have been stopped in the event of a change in the vaccine, and if anyone has obtained an appointment, the doctor is obligated to explain to the person that there is no need to take a fourth dose of vaccination, and if the doctor does not explain this matter, he has failed in performing his duty .

She pointed out that signing a declaration bearing responsibility when taking the vaccine is a legal aspect that is present in all vaccinations, as the main objective of the approval is to confirm the approval of obtaining the vaccine, but this declaration does not hold the person all responsibility for taking the vaccine in the event of complications,

There is a responsibility on the vaccine manufacturer, and the party that licensed the vaccine.

Al Hosani said that during the “Covid-19” pandemic, some legal aspects were clarified, and during the emergency use of the drug, it was clarified that this is an emergency use to provide the person with real information that there is a difference between the emergency use and the full use of the drug, and this was also done with the beginning of providing the support dose. As there were not enough studies for it, it was mentioned in the medical declaration to clarify the matter.

She added that the types of acknowledgments differ according to the case, as there is a special acknowledgment for the change in the type of vaccine in the booster dose, which indicates that the person was given the option to take the third dose of the same vaccine, or from a different vaccine, and there is also an acknowledgment for people who insist on taking a fourth dose of The vaccine. In these cases, giving the additional dose in the absence of clear medical evidence, or proof of the effectiveness and safety of this practice, is the responsibility of the person himself and he signs an acknowledgment that he bears responsibility for the decision to take the fourth dose.



She stressed that clinical trials are global practices, conducted to determine the accuracy and effectiveness of any drug, and participants are selected in at least two groups, the first to get the actual drug, and the second to get the placebo, which is the same form of the drug, but does not have any content, in order to study the effect The actual drug versus the psychological effect, where immunity rises naturally when the person believes that he has obtained the drug. The aim of this is to differentiate between the real effect of the drug and the psychological effect that is formed as a result of the person's belief that he has obtained the drug, and to compare the immunity of each group.

She said that during clinical trials, the doctor or the person participating is not informed of the content of the medicine he took, but the person receives a certificate of vaccination, and at the end of the study they are informed and people who receive the dummy vaccine are given the necessary doses of the vaccines, noting that communication is currently being conducted with Persons participating in the clinical study to indicate the quality and content of the ingredient they took during the study period.

Follow our latest local and sports news and the latest political and economic developments via Google news